BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bartolini I, Bencini L, Risaliti M, Ringressi MN, Moraldi L, Taddei A. Current Management of Pancreatic Neuroendocrine Tumors: From Demolitive Surgery to Observation. Gastroenterol Res Pract 2018;2018:9647247. [PMID: 30140282 DOI: 10.1155/2018/9647247] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Venugopal A, Michalczyk A, Khasraw M, Ackland ML. EMT Molecular Signatures of Pancreatic Neuroendocrine Neoplasms. IJMS 2022;23:13645. [DOI: 10.3390/ijms232113645] [Reference Citation Analysis]
2 Ren SJ, Wang X, Ke NW, Tan QQ, Yang F, Yao WQ, Tan CL, Liu XB. Clinicopathological features and long-term prognosis of purely cystic pancreatic neuroendocrine tumors: A single center experience. Asian J Surg 2022:S1015-9584(22)00975-7. [PMID: 35850904 DOI: 10.1016/j.asjsur.2022.07.029] [Reference Citation Analysis]
3 Bösch F, Ghadimi M, Angele MK. Personalisierte Resektionsverfahren bei neuroendokrinen Neoplasien des Pankreas. Zentralbl Chir 2022;147:264-269. [DOI: 10.1055/a-1823-1275] [Reference Citation Analysis]
4 Clement D, Navalkissoor S, Srirajaskanthan R, Courbon F, Dierickx L, Eccles A, Lewington V, Mitjavila M, Percovich JC, Lequoy B, He B, Folitar I, Ramage J. Efficacy and safety of 177Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study. Eur J Nucl Med Mol Imaging 2022. [PMID: 35389069 DOI: 10.1007/s00259-022-05771-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Pausch TM, Liu X, Cui J, Wei J, Miao Y, Heger U, Probst P, Heap S, Hackert T. Survival Benefit of Resection Surgery for Pancreatic Ductal Adenocarcinoma with Liver Metastases: A Propensity Score-Matched SEER Database Analysis. Cancers (Basel) 2021;14:57. [PMID: 35008223 DOI: 10.3390/cancers14010057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Segaran N, Devine C, Wang M, Ganeshan D. Current update on imaging for pancreatic neuroendocrine neoplasms. World J Clin Oncol 2021; 12(10): 897-911 [PMID: 34733612 DOI: 10.5306/wjco.v12.i10.897] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Bencini L, Urciuoli I, Trafeli M, Paolini C, Moraldi L, Tribuzi A, Pacciani S, Coratti A. Robotic pancreatic surgery: minimally invasive approach to challenging operations. Minerva Surg 2021;76:138-45. [PMID: 33908238 DOI: 10.23736/S2724-5691.21.08435-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Benedetti G, Mori M, Panzeri MM, Barbera M, Palumbo D, Sini C, Muffatti F, Andreasi V, Steidler S, Doglioni C, Partelli S, Manzoni M, Falconi M, Fiorino C, De Cobelli F. CT-derived radiomic features to discriminate histologic characteristics of pancreatic neuroendocrine tumors. Radiol Med 2021;126:745-60. [PMID: 33523367 DOI: 10.1007/s11547-021-01333-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 36.0] [Reference Citation Analysis]
9 Ozretić L, Simonović AV, Rathbone ML, Young MPA, Perez-Machado MA. The benefits of the Papanicolaou Society of Cytopathology System for reporting pancreatobiliary cytology: A 2-year review from a single academic institution. Cytopathology 2021;32:227-32. [PMID: 33415845 DOI: 10.1111/cyt.12949] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Bispo M, Caldeira A, Leite S, Marques S, Moreira T, Moutinho-Ribeiro P, Nunes N. Endoscopic Ultrasound-Guided Ablation of Focal Pancreatic Lesions: The GRUPUGE Perspective. GE Port J Gastroenterol 2020;27:410-6. [PMID: 33251290 DOI: 10.1159/000507895] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Wan Y, Hao H, Meng S, Li Z, Yu F, Meng Chi, Chao Q, Gao J. Application of low dose pancreas perfusion CT combined with enhancement scanning in diagnosis of pancreatic neuroendocrine tumors. Pancreatology 2021;21:240-5. [PMID: 33191144 DOI: 10.1016/j.pan.2020.10.046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Keen F, Iqbal F, Owen P, Christian A, Kumar N, Kalhan A. Metastatic insulinoma presenting 14 years after benign tumour resection: a rare case and management dilemma. Endocrinol Diabetes Metab Case Rep 2020;2020:EDM200065. [PMID: 33434180 DOI: 10.1530/EDM-20-0065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Bösch F, Belyaev O, Brunner M, Müller-Debus CF, Grützmann R, Keck T, Uhl W, Witzigmann H, Werner J; Olga Radulova-Mauersberger. [Indications for the Surgical Management of Pancreatic Neuroendocrine Neoplasms]. Zentralbl Chir 2020;145:365-73. [PMID: 32599635 DOI: 10.1055/a-1168-7103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Yalkin O, Uzunoglu MY, Altintoprak F, Muhtaroglu A. Coexisting giant splenic artery aneurysm and non-functioning pancreatic neuroendocrine tumor. Pak J Med Sci 2020;36:843-5. [PMID: 32494285 DOI: 10.12669/pjms.36.4.1869] [Reference Citation Analysis]
15 Chin KM, Goh BKP. Robotic enucleation of a pancreatic uncinate neuroendocrine tumor - a unique parenchyma-saving strategy for uncinate tumors. Ann Hepatobiliary Pancreat Surg 2020;24:97-103. [PMID: 32181437 DOI: 10.14701/ahbps.2020.24.1.97] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Ishida H, Lam AK. Pancreatic neuroendocrine neoplasms: The latest surgical and medical treatment strategies based on the current World Health Organization classification. Critical Reviews in Oncology/Hematology 2020;145:102835. [DOI: 10.1016/j.critrevonc.2019.102835] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
17 Akirov A, Larouche V, Alshehri S, Asa SL, Ezzat S. Treatment Options for Pancreatic Neuroendocrine Tumors. Cancers (Basel) 2019;11:E828. [PMID: 31207914 DOI: 10.3390/cancers11060828] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 12.0] [Reference Citation Analysis]
18 Zhu JK, Wu D, Xu JW, Huang X, Jiang YY, Edil BH, Li M, Hu SY, Zhan HX. Cystic pancreatic neuroendocrine tumors: A distinctive subgroup with indolent biological behavior? A systematic review and meta-analysis. Pancreatology 2019;19:738-50. [PMID: 31160191 DOI: 10.1016/j.pan.2019.05.462] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]